References
O’Reilly KE, Patel U, Chu J, Patel R, Machler BC. Chemical leukoderma. Dermatol Online J 2011; 17: 29.
Solano F, Briganti S, Picardo M, Ghanem G. Hypopigmenting agents: an updated review on biological, chemical and clinical aspects. Pigment Cell Res 2006; 19: 550–71.
Katoulis AC, Alevizou A, Bozi E, et al. A randomized, double–blind, vehicle–controlled study of a preparation containing undecylenoyl phenylalanine 2% in the treatment of solar lentigines. Clin Exp Dermatol 2009; 35: 473–6.
Hakozaki T, Minwalla L, Zhuang J, et al. The effect of niacinamide on reducing cutaneous pigmentation and suppression of melanosome transfer. Br J Dermatol 2002; 147: 20–31.
Bissett DL, Robinson LR, Raleigh PS, et al. Reduction in the appearance of facial hyperpigmentation by topical N–undecyl–10–enoyl–l–phenylalanine and its combination with niacinamide. J Cosmet Dermatol 2009; 8: 260–6.
Yoshikawa M, Sumikawa Y, Hida T, et al. Clinical and epidemiological analysis in 149 cases of rhododendrol–induced leukoderma. J Dermatol 2017; 44: 582–7.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Cho, M., Otsuka, A., Irie, H. et al. A case of possible chemical leukoderma secondary to usage of skin whitening agents. Eur J Dermatol 28, 701–702 (2018). https://doi.org/10.1684/ejd.2018.3380
Published:
Issue Date:
DOI: https://doi.org/10.1684/ejd.2018.3380